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Abstract 
We compared the efficacy of using HTK solution with that of University of 
Wisconsin (UW) solution for heart preservation in an isolated rat heart 
preparation. Nicorandil (NCR) exerts its action as an ATP-sensitive potassium 
channel opener at low extracellular potassium concentrations, and HTK 
solution has a low potassium concentration. Therefore, we also investigated 
the efficacy of using HTK solution with NCR following 12-hour preservation. 
Hearts isolated from male Wistar rats were mounted on a Langendorff 
apparatus to estimate baseline aortic flow (AF), coronary flow (CF), cardiac 
output (CO), heart rate (HR), systolic pressure (SP), aortic mean pressure, and 
the rate-pressure product (RPP). The hearts were divided into 4 groups: 
Group 1, 8-hour storage in UW solution; Groups 2 and 3, 8 or 12-hour 
storage in HTK solution, respectively; Group 4, 12-hour storage in HTK 
solution with NCR. They were arrested and stored at 4oC in each preservation 
solution. Following storage, they were reperfused and post-preservative 
function was measured to assess cardiac functional recovery. Concentrations 
of CPK, troponin-T, and lactate in the coronary perfusate were measured. 
Frozen tissue samples from Groups 3 and 4 were analyzed for adenylate 
content and cyclic-GMP. The myocardial water content was also measured. 
The recovery of AF, CF, CO, SP, and RPP in Group 2 were significantly 
improved compared with that in Group 1 (p<0.05). The recovery of AF, CF, 
CO and HR in Group 4 were significantly better than in Group 3 (p<0.05). 
CPK leakage in Group 2 and Troponin-T leakage in Group 4 were 
significantly reduced (p<0.05 vs Group 1 and 3, respectively). Total adenine 
nucleotides and the adenylate energy charge in Group 4 were well-sustained 
(p<0.05 vs Group 3). These results suggest that HTK solution is more 
effective than UW solution for cardiac preservation, and that NCR provides 
better protection still more. 
Introduction 
Following the introduction of University of Wisconsin (UW) solution, 
the preservation times of solid organs have been markedly extended, both in 
animal and clinical experiments (1-6). However, the generally accepted time 
limit for safe cold storage for clinical heart trasplantation remains only 4 to 6 
hours (7). HTK organ preservation solution was initially developed by 
Bretschneider and coworkers as a cardioplegic solution (8). The protective 
effect of HTK solution is based on the high buffering capacity provided by 
histidine, restricting tissue acidosis induced by ischemia. HTK solution has 
been reported to be effective in experimental kidney transplantation, and a 
clinical trial is currently underway (9, 10). The purpose of this study is to 
assess the efficacy of HTK solution as compared with UW solution in 
experimental heart preservation . 
Nicorandil (NCR), nitrate and K ATP channel opener, has a remarkable 
coronary vasodilating effect and is being used as a theraputic drug for angina 
(11-14). Moreover, it has been reported that NCR has cardioprotective 
effects, through the attenuation of ATP depletion (15), and protection against 
free radicals (16). Therefore, we also investigated the effect of NCR on 
myocadial protection during simple cold storage. 
Materials and Methods 
Isolated rat heart preservation 
Animal experimentation was performed in accordance with institutional 
guidelines of the Guide for the Care and Use of Laboratory Animals 
published by the U.S. Department of Health and Human Services. Male Wistar 
rats (250 to 350 g) were systemically heparinized (500 IU intraperitoneally 
(i.p.) ], and anesthetized with sodium pentobarbital (65 mg/kg i. p.). The heart 
was excised and immediately immersed in Krebs-Henseleit bicarbonate buffer 
(KHB), consisting of (mmol/L): NaCJ (118), KCl (4.7), MgS04 (1.2), 
KH2P04 (1.2), CaCl2 (2.5), NaHC03(25.0), and glucose (11.0) at 37°C. Then, 
it was mounted on a Langendorff apparatus (IPH-W, Labo Support, Osaka, 
Japan) via the aorta, and perfused with KHB solution at a constant pressure of 
65 mmHg for 3 minutes in Langendorff mode (L-mode). KHB solution was 
filtered (48 ,urn), equilibrated with 95% 02 and 5% C02, and maintained at 
37°C. During preparation, care was taken to cannulate the excised hearts 
rapidly to minimize the ischemic time. Following cannulation of the left 
atrium (LA) via the pulmonary vein, the heart was switched to working mode 
(W-mode) with an LA perfusion pressure of 10 mmHg and an afterload of 60 
mmHg. Baseline function was determined following 2 minutes of W-mode. 
Measurements were as follows. aortic flow (AF), coronary flow (CF), cardiac 
output (CO), heart rate (HR), systolic pressure (SP), aortic mean pressure 
(MP) and rate pressure product (RPP, HR x max SP). Following 
measurement of pre-preservative cardiac function, the heart was switched 
back to L-mode. 
Experimental protocol 
Experimental protocol is shown in Figure 1. The hearts were divided into 
four groups (n=5 to 8 hearts per groups): Group 1 (n=7), 8-hour storage in 
UW solution; Group 2 (n=8), 8-hour storage in HTK solution; Group 3 (n=5), 
12-hour storage in HTK solution; Group 4 (n=6), 12-hour storage in HTK 
solution with NCR 10-4 M. The hearts in all groups were arrested by 
administration of each preservation solution (60 mL/kg at 4oC) via the aortic 
cannula at a pressure of 60 mmHg. Then, they were stored in each 
preservation solution (30mL) at 4 °C. Table 1 shows the compositions of the 
preservation solutions . Following cold storage, they were mounted on a 
Langendorff apparatus again, and reperfused for 15 minutes on L-mode. 
Then, they were switched to W-mode. The coronary perfusate was collected 
following 10 minutes of W-mode reperfusion to evaluate for lactate, CPK, and 
troponin-T in each preservation group. Lactate was measured according to an 
enzymatic method, CPK according to Ultra Violet method and troponin-T 
according to an enzyme immunoassay method. Cardiac functional recovery of 
the stored heart was measured at the end of 25 minutes of W -mode 
reperfusion. Following evaluation of the stored heart, LV dp/dt (mmHg/sec) 
was measured by puncture via the left ventricular apex. A ventricular 
specimen was weighed immediately, dried at 80oC to constant weight, and 
reweighed following 24 hours. Water content was computed using the 
following formula: water contents (%) = (wet weight - dry weight)/ wet 
weight x 100. 
Biochemical analysis 
Frozen myocardial samples in liquid nitrogen just after storage in the 
solution of Group 3 and Group 4 were analyzed for adenylate content and 
cyclic-GMP (c-GMP). 
Adenylate content 
Frozen myocardium was centrifuged (11,000 g for 5 minutes at 4°C) 
before removal of the supernatant and neutralization with potassium 
hydroxide (2 mol/L). Aliquots (20 ,ul) were taken for analysis by high 
performance liquid chromatography. The values obtained were used to 
calculate the following indices of myocardial energy status: total adenine 
nucleotides (TAN)= ATP + ADP +AMP and adenylate energy charge= (0.5 
ADP + ATP)/ (ATP + ADP +AMP). 
Cyclic-GMP 
Frozen myocardium was homogenated lml of 0.1 N HCI and centrifugal at 
25000g for 15 min. The c-GMP content in the supernatant was measured for 
radioimmunoassay. 
Chemicals 
Nicorandil was obtained from Chuugai Pharmaceutical. Co. LTD, Japan. 
Statistical analysis 
All results are expressed as the means ± SE. A statistical analysis was 
performed by Student's unpaired t test. A p value of less than 0.05 was 
considered statistically significant. 
Results 
Baseline cardiac function 
The mean values of baseline cardiac function (n=26), measured prior to 
preservation, were as follows; 45.7± 2.7 ml/min of AF, 15.7±0.8 ml/min of 
CF, 64.2 ±1.3 ml/min of CO, 228.8 ±10.7 beats/min of HR, 108.3 ±3.6 mmHg 
of SP and 23347 ±344 of RPP. 
Cardiac functional recovery 
Table 2 shows the recovery of hemodynamic data on the heart for 8 or 12 
hours of preservation ((A), absolute values of post-preservative cardiac 
function; (B), percentage values to the pre-preservative baseline function). 
Following 8 hours of preservation , the recovery of AF, CF, CO, SP, and RPP 
in Group 2 was significantly increased compared witb that in Group 1. 
Following 12 hours of preservation , the recovery of AF, CF, CO and HR in 
Group 4 was higher than that in Group 3 (p<0.05). There were no significant 
·differences in SP, RPP or LV dp/dt between Group 3 and 4. 
CPK, Lactate and Troponin-T leakage 
There was a significant decrease in CPK leakage in Group 2, compared 
with Group 1 (Table 3). Troponin-T leakage in Group 4 decreased 
significantly, compared with Group 3 (Table 3). There were no significant 
differences in lactate leakage among the four groups. 
Adenylate contents and cyclic-GMP 
TAN and EC were maintained better in Group 4, compared with Group 3 
(p<0.05) (Table 4). There were no significant differences in c-GMP levels. 
Water content 
The tissue water content was 83.2 ±0.4% in Group 1, 82.6 ±0.5 % in 
Group 2, 83.4 ± 0.3% in Group 3, and 82.9 ±0.8% in Group 4. There were 
no statistically significant differences among the groups. 
Discussion 
A "universal " preservation solution would be suitable for preservation of 
all organs, and would increase the simplicity of the overall harvesting 
procedure. Numerous preservation solutions have been proposed and 
experimentally evaluated in response to the need for extending the safe limit 
of organ preservation. University of Wisconsin (UW) solution has been 
demonstrated to provide significant improvement in organ function after the 
extended preservation of kidneys, livers and pancreases {1 -6). Several studies 
have compared UW solution with other preservation solutions for the heart, 
and have found it superior (17, 18), however the clinically safe time limit 
remains only 4 to 6 hours (7). HTK solution has been reported to be effective 
in kidney and liver transplantation (9, 10, 19,20). However, it has not been as 
extensively tested for use with the donor heart (21). Hendry et al. have 
reported better recovery of human right atrial trabeculae contracting 
isometrically in vitro after preservation with HTK solution, compared with 
UW solution {22). 
In this study, we examined the cardiac functional recovery of the whole 
heart in a working mode where cardiac function could be evaluated more 
precisely, and found a better recovery of cardiac function and less leakage of 
CPK in the group preserved with HTK solution, compared with that preserved 
with UW solution, following an 8- hour storage. During cold storage, 
intracellular pH drops as H+ and lactate accumulate and ATP is depleted, 
which causes dysregulation of cellular homeostasis and leads to cell injury 
(23). The suppression of ischemia-induced tissue acidosis and sustenance of 
cytosolic ATP pools by the high buffering capacity provided by histidine (20) 
might have lead to the better cardiac functional recovery with HTK solution in 
our study. 
During cold storage in the presence of a low intracellular pH, a high 
potassium concentration has been shown to lead to myocardial damage (24). 
Another study has also revealed that a high potassium concentration might be 
harmful to the endothelium (25). Therefore, HTK solution, which has a low 
potassium concentration, might provide excellent protection. The much higher 
potassium concentration in UW solution is than in HTK solution might not be 
suitable for cardiac preservation. 
In UW solution, raffinose, lactobionate, and colloid hydroxyethyl starch 
suppress the parenchymal cell swelling induced by hypothermia. In HTK 
solution, histidine, apart from being a buffer, appears to be effective in 
preventing cell swelling. The impermeability of UW solution has been 
reported to be superior to that of HTK solution for long-term preservation 
beyond 24 hours (20). However, considering graft viability, it may not be 
possible to preserve a heart for such a long time. In the present study, the 
tissue water content fo llowing an 8- or 12-hour preservations revealed no 
statistically significant differences with the preservation solution. The 
inhibitory effect on cell swelling in HTK solution might be as good as that in 
UW solution, during short-period preservation as in this study. 
Recently, Nicorandil (NCR) has drawn attention for its cardioprotective 
effect in ischemia and reperfusion injury through a dual mechanism of action 
involving nitrate effects via activation of guanylate cyclase, and the opening of 
K ATP channels (11-14). Therefore, in this study, we added NCR to HTK 
solution, preserved hearts in it for 12 hours, and found much better recovery 
of cardiac function, and a significant decrease in troponin-T leakage following 
12-hour storage, compared with that without NCR. The total adenine 
nucleotides and adenylate energy charge of hearts preserved in HTK solution 
with NCR were better sustained than those of hearts preserved in HTK 
solution without NCR. 
During cold storage, energy is used in the preserved myocyte to maintain 
intracellular homeostasis, particularly that of calcium. As energy stores are 
depleted, the myocyte can no longer control its internal homeostasis, and the 
sarcoplasmic reticulum and mitochondria can no longer maintain their 
sequestration of calcium. Calcium is then released in the cytosome to 
contracture by interacting with tropomyosin, creating a high-affinity 
actin-myosin state. The actin and myosin interact causing a progressive and 
irreversible contracture of the heart (26,27). At reperfusion, intracellular 
Ca2+ influx is increased further and myocardial damage is accelerated. NCR, 
which activates the KArP channels may decrease the action potential duration 
and attenuate membrane depolarization. These effects may lead to a decrease 
in the free cytosolic calcium concentration, a rapid loss of contractile activity, 
and a reduced level of adenosine triphosphate (ATP) utilization, which prevent 
myocardial injury during preservation and reperfusion (P/R). 
The action of NCR as the K ATP channel opener has been reported to be 
more effective when the extracellular potassium concentration is below 24 
mM (28). The potassium concentration in HTK solution is 10 mM, and that in 
UW solution is 125 mM. Therefore, in this study, we added NCR just to HTK 
preservation solution and found a better cardiac functional recovery, 
following P/R. 
In this study, we measured myocardial c-GMP as a marker of nitric oxide, 
since NCR has a nitrate action in addition to K ATP channel opening action. 
Myocardial c-GMP might increase in hearts stored in HTK solution with NCR, 
because of the nitrate effect. However, there were no significant differences in 
myocardial c-GMP concentrations between the hearts stored in HTK solution 
with NCR and those stored in HTK solution without NCR. In our study, the 
coronary flow of hearts preserved in HTK solution with NCR increased 
significantly, compared with those preserved in HTK solution without NCR. 
During cold storage, thus, the K ATP channel effect of NCR appears to be more 
prominent than its nitrate effect. 
In conclusion, HTK. solution is much more effective than UW solution for 
heart preservation, and HTK preservation solution with NCR provides further 
protection, which may lead to better techniques of heart preservation for 
transplantation. 
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Table 1. Composition of the preservation solutions 
HTK uw 
NaCI 15 KH2P04 25 
KCI 9 KCI 5 
MgCb 4 Adenosine 5 
K-ketoglutarate 1 Glutathione 3 
Histidine 180 MgS04 5 
Histidine HCI 18 Raffinose 30 





TABLE 2. (A) Cardiac Functional Recovery 
Time AF CF CO HR 




(x 1 03) 
1. uw 8 20.4±2.8 8.3±1.1 30.8±1.9 207±24 76.3±2.2 16.8±0.5 
(n =7) 
2. HTK 8 33.1 ±4.1* 14.4±0.9* 49.1 ±3 .7* 214±18 98.7±6.7* 20.4±1.2* 
(n=8) 
3. HTK 12 3.5±0.5 6 .6±0.5 9.8±1.2 138± 7 66 .3±6 .6 1 0.8±1.0 
(n =5) 
4. NCR 1 2 6. 0 ± 1 . 2 # 11 . 2 ±0. 7 # 1 8. 4 ± 3 . 0 # 1 9 6 ± 1 4 # 6 7. 2 ± 3. 4 1 2. 2 ± 1 . 6 
(n=6) 
r- -------------------------------------------------------------------





1. uw 8 47.4±4.2 
(n=7) 
2. HTK 8 71.5 ±8.6* 
(n=8) 
3. HTK 12 7.2 ±1.0 
(n=5) 























90 .1 ±4.6* 





83 .6 ±4.6* 
43.0±3. 9 
47.2±4.9 
Data are expressed as mean±S.E. The hemodynamics of the pre-preservative hearts 
were: AF(45.7±2.7 ml / min), CF(15.7 ±0.8 ml/ min), C0(64.2±1.3 ml /mi n), HR(229±11 
beats/ min), SP(1 08±3.6 mmHg). and RPP (23347±344}. 
*p<0.05 vs Group 1 , #p<0.05 vs Group 3 
NCR, HTK solution with Nicorand il 10-4 M 
AF, aortic fl ow ; CF, coronary flow; CO, cardiac output; HR, heart rate ; 
SP, systolic pressure; RPP, rate pressure product 
Table 3. CPK, Troponin-T and Lactate leakage 
Time CPK Tn-T Lactate 
(hours) (IU/min/g) (ng/min/g) (mg/min/g) 
1. uw 8 0.06 + 0.02 19.7 + 3.4 10.3 + 0.7 
(n=7) 
2. HTK 8 0.01 + 0.00 * 26.7+9.8 6.5 + 2.1 (n=8) 
3. HTK 12 
(n=5) 0.3 + 0.3 
37.5 + 8.9 10.1 + 1.7 
4. NCR 12 o.o1 + o.oo 8.9 + 2.0 * 13.4 + 2.1 (n=6) 
Values are mean + S.E. * p<0.05 vs Group 1 *P<0.05 vs Group 3 
CPK: creatine phosphokinase, Tn-T: troponin-T, NCR: HTK solution with Nicorandil1o-4 M 
c 
Table 4. Adenylate contents and cyclic-GMP 
Time TAN Energy c-GMP 
(hour) ( 1J mol/g) Charge (p mol/g) 
Group 3 8.1 0.22 13.3 
12 +o.5 +0.03 +0.3 (n=5) 
Group 4 14.9 * 0.53* 13.0 12 
+0.6 +1.0 (n=6) +o.os 
Values are mean + SE. * p < 0.05 vs Group 3 























Figure 1. Experimental Protocol. The hearts were excised and 
mounted on a Langendorf£ apparatus (CD). They were arrested and 
stored for 8- or 12-hours, following measurement of baseline cardiac 
function in a W-mode (CV, @). Following cold storage, they were 
reperfused for 15 minutes on L-mode and 25 minutes on W-mode. 
The coronary perfusate was collected following 10 minutes of W-
mode reperfusion to evaluate for lactate, CPK, and troponin-T (@). 
Cardiac functional recovery was measured at the end of W-mode 
reperfusion (@). 
W: working mode perfusion, L: Langendorf£ mode perfusion, CPK: 
creatine phosphokinase 
c ( _ 
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Abstract 
We investigated the efficacy in reducing myocardial preservation and 
reperfusion (P/R) injury of direct hydroxyl radical scavenging by nicaraven as 
compared with scavenging of both superoxide radicals and hydrogen 
peroxides by superoxide dismutase (SOD) and catalase (CAT), respectively. 
Isolated rat hearts were mounted on a Langendorff (L) apparatus to estimate 
the baseline aortic flow (AF), coronary flow (CF), cardiac output (CO), 
systolic pressure (SP), aortic mean pressure (MP), double product, and LV 
dp/dt. They were divided into 3 groups: Group 1, 12-hour storage in HTK 
solution; Groups 2, 12-hour storage in HTK solution containing 2.5 x 105 U/L 
SOD and 102 mg/L CAT; Group 3, 12-hour storage in HTK solution 
containing 10-3M nicaraven. SOD and CAT, and nicaraven were administered 
intraperitoneally before harvesting. Hearts were stored in each preservation 
solution at 4oC, and then reperfused. Post-preservative function and 
concentrations of leaked enzymes were measured. The hearts were switched 
back to the L-mode and paced at 330 beats/min. CF following perfusion with 
Krebs-Henseleit bicarbonate buffer (KHB) solution containing 10-6M 5-
hydroxytryptamine (5-HT) or 10-5 M nitroglycerin (NTG) was expressed as a 
percentage of that perfused with drug-free KHB solution in each group. The 
myocardial water content also was measured. The recovery of CF, CO, SP, 
r MP, and LV dp/dt was significantly greater in Group 3 than in Group 1. The 
recovery of CF was superior to that in Group 2 (p<0.05). There were no 
significant differences in the recovery of cardiac function, between Groups 1 
and 2. 5-HT caused a decrease in CF in each group, however, CF in Group 3 
. 
was higher than that in Group 1 (p<0.05). NTG caused no significant 
differences among the groups. There were no significant differences in leaked 
enzymes and myocardial water content among the three groups. These results 
suggest that nicaraven protects against myocardial P/R injury through its 
hydroxyl radical scavenging activity, and that the therapy by oxygen-free 
radical scavengers might be preferentially toward inactivation of hydroxyl 
radicals rather than superoxide radicals and/or hydrogen peroxides. 
Abbreviations: AF; aortic flow, CAT; catalase, CF; coronary flow, CO; 
cardiac output, CPK; creatine phosphokinase, EDRF; endothelium-derived 
relaxing factor, HR; heart rate, i.p.; intraperitoneally, 5-HT; 5-
hydroxytryptamine, KHB; Krebs-Henseleit bicarbonate buffer, LA; left 
atrium, L; Langendorff, LV; left ventricle, MP; aortic mean pressure, NTG; 
nitroglycerin, P/R; preservation and reperfusion, RPP; rate pressure product, 
SOD; superoxide dismutase, SP; systoric pressure, SR; sarcoplastic reticulum, 
TAN; total adenine nucleotides, UW; University of Wisconsin, W; working 
Introduction 
Following the development of improved techniques, the preservation 
times of solid organs have been markedly extended. However, the generally 
accepted time limit for safe cold storage for clinical heart transplantation 
remains only 4-6 hours (1). It is thought that, during the ischemic period, 
there is an increase in the formation of free radicals that is greatly accelerated 
with the sudden reintroduction of oxygen at the onset of reperfusion; this leads 
to vascular damage and myocardial dysfunction (2). It has been suggested that 
free radicals, thus, are an important contributing factor in the development of 
reperfusion injuries (3,4). 
The oxygen-derived free radicals and their metabolites include the 
superoxide radical, hydrogen peroxide, and the hydroxyl radical (5). The 
superoxide radicals and the hydrogen peroxide have a relatively low cellular 
reactivity in the absence of a transition metal such as iron (6, 7). Instead, in the 
presence of iron, cellular injury is more likely related to the subsequent 
generation of the highly reactive hydroxyl radical via a superoxide-driven 
iron-catalyzed Fenton reaction (8), where superoxide radicals react directly 
with hydrogen peroxide to form hydroxyl radicals. Hydroxyl radicals are 
very reactive species that can interact with membranes and proteins, causing 
lipid peroxidation, protein denaturation, and altered membrane permeability 
(9). 
Hydroxyl radical formation might be prevented by the simultaneous 
scavenging of both superoxide and hydrogen peroxide radicals. This is 
illustrated by the beneficial effects of the combined administration of 
superoxide dismutase (SOD) and the hydrogen peroxide scavenger, catalase 
(CAT), on reperfusion injury (10,11). However, it remains controversial 
whether an exogenous supply of these enzymes effectively reduces free 
radicals and improves cardiac function after ischemia and reperfusion (12, 13). 
Other investigators have reported that treatment with scavengers of 
hydroxyl radicals or agents that directly prevent their formation might reduce 
myocardial reperfusion injury (14-18). Some hydroxyl radical scavengers 
previously have been tested with regard to their ability to reduce myocardial 
reperfusion injuries, however, their efficacy remains controversial (19-26). 
Nicaraven, 1, 2-bis(nicotinamide )-propane, has been reported to suppress lipid 
peroxidation by scavenging hydroxyl radicals and has shown a beneficial 
effect in the treatment of prolonged cerebral vasospasm after subarachnoid 
hemorrhage (27-30). Nicaraven, thus, might be able to reduce the 
development of myocardial and/or coronary vascular reperfusion injury 
following preservation. 
The present study was designed by measuring cardiac function to evaluate 
the efficacy of direct hydroxyl radical scavenging by nicaraven, compared 
with scavenging of both superoxide radicals and hydrogen peroxides by SOD 
and CAT, respectively, in reducing myocardial preservation and reperfusion 
(P/R) injuries. In addition, we compared the protective effects of nicaraven on 
coronary vascular damage following P/ R, with that in untreated-controls and 
those receiving combined treatment with both SOD and CAT (SOD & CAT). 
Materials and Methods 
Isolated rat heart preparation 
Animal experimentation was performed in accordance with institutional 
guidelines of the Guide for the Care and Use of Laboratory Animals 
published by the U.S. Department of Health and Human Services. Male Wistar 
rats (250 to 350 g) were systemically heparinized [500 IU intraperitoneally 
(i.p.) ], and anesthetized with sodium pentobarbital (65 mg/kg i. p.). The heart 
was excised and immed iately immersed in Krebs-Henseleit bicarbonate buffer 
(I<HB) solution, consisting of (mmol/L): NaCl (118), KCI ( 4. 7), MgS04 (1.2), 
KH2P04 (1.2), CaC12 (2.5), NaHC03(25.0), and glucose (11.0) at 37°C. 
Then, it was mounted on a Langendorf[ apparatus (IPH-W, Labo Support, 
Osaka, Japan) via the aorta, and perfused with KHB solution at a constant 
pressure of 60 mmHg for 3 minutes in Langendorf£ mode (L-mode). KHB 
solution was filtered (48 ,urn), equilibrated with 95 % 02 and 5% C02, and 
maintained at 37°C. KHB perfusate in this circuit is not recycled. During 
preparation, care was taken to cannulate the excised hearts rapidly to minimize 
the ischemic time. Following cannulation of the left atrium (LA) via the 
pulmonary vein, the heart was switched to working mode (W-mode) with an 
LA perfusion pressure of 10 mmHg and an afterload of 60 mmHg. Baseline 
function was determined following 2 minutes of W -mode. Measurements were 
as follows: aortic flow (AF), coronary flow (CF), cardiac output (CO), heart 
rate (HR), systolic pressure (SP), mean pressure (MP) and rate pressure 
product (RPP, HR x max SP). 
Experimental protocol 
Experimental protocol is shown in Figure 1. The hearts were divided into 
three groups (n=8 hearts per groups): Group 1, 12-hour storage in HTK 
solution; Group 2, 12-hour storage in HTK solution with 2.5 x 105 U/L SOD 
and 102 mg/ L CAT; Group 3, 12-hour storage in HTK solution with 10-3 M 
nicaraven. 1.3 x 105 U SOD and 1.5 x 102 mg CAT, and 4 x 10-4 M 
nicaraven were administered intraperitoneally in Group 2 and 3, respectively, 
15 minutes before harvesting. The hearts in all groups were arrested by 
administration of each preservation solution (50 mL/ kg body weight at 4 oC) 
via the aortic cannula at a pressure of 60 mmHg. Then, they were stored in 
each preservation solution (30mL) at 4°C. Following cold storage, they were 
mounted on a Langendorf£ apparatus again, and reperfused with KHB solution 
for 15 minutes on L-mode. Then, they were switched to W-mode. The 
coronary perfusate was collected following 10 minutes of W-mode 
reperfusion to evaluate for lactate, CPK, and troponin-T in each preservation 
group. Lactate, CPK, and troponin-T were determined as previously described 
(Ref 31, in press). Cardiac functional recovery of the stored heart was 
measured at the end of 25 minutes of W-mode reperfusion. Following 
evaluation of the stored heart, LV dp/dt (mmHg/sec) was measured by 
puncture via the left ventricular apex (Pressure Transducer, Nihon Kohden 
Corp., Tokyo, Japan), and the heart was switched back to L-mode and paced 
in an atrial mode at 330 beats/min (PGM-330, Labo Support, Osaka, Japan). 
The hearts were, then, perfused with the drug-free KHB solution for 20 
minutes for stabilization, during which CF was measured continuously. After 
stabilization, the hearts were perfused with KHB solution containing 10-6 M 
5-hydroxytryptamine (5 -HT) for 15 minutes and CF was recorded for the last 
2 minutes of perfusion. The coronary circulation was washed with the 
drug-free KHB for the next 20 minutes to reestablish the basal CF. The hearts 
subsequently were perfused with KHB solution containing 10-5 M 
nitroglycerin (NTG) for 15 minutes and CF was measured for the last 2 
minutes of perfusion. The increase in CF after perfusion with KHB solution 
containing 5-HT or NTG was calculated and expressed as a percentage of that 
of the heart perfused with drug-free KHB solution in each group. 
A ventricular specimen was weighed immediately, dried at 80oC to 
constant weight, and reweighed fo llowing 24 hours. Water content was 
computed using the following formula: water contents (%) = (wet weight -
dry weight)/ wet weight x 100. 
Chemicals and reagents 
Nicaraven, 1, 2-bis(nicotinamide )-propane was obtained from Chuugai 
Pharmaceutical. Co. LTD, Japan, 5-hydroxytryptamine (5-HT) from Wako 
Pure Chemical Industries, LTD, Japan, nitroglycerin (NTG) from Nippon 
Kayaku Co., LTD, Japan, SOD and CAT from Sigma Chemical, Co.LTD, 
USA. 
Statistical analysis 
All results are expressed as the means ± S.E. Statistical evaluation of the 
data was performed by one-way ANOVA and Scheffe's F-test. A p value of 
less than 0.05 was considered statistically significant. 
Results 
Baseline cardiac function 
The mean values of baseline cardiac function (n=24), measured prior to 
preservation, were as follows; 46.4 ± 2. 9 ml/min of AF, 15.4 ± 1.1 ml/min of 
CF, 61.3 ± 3.4 ml/min of CO, 238.8 ± 14.6 beats/min of HR, 112.3 ± 4.6 
mmHg of SP, 55.3 ±0.6 mmHg of MP and 25634 ± 421 mm Hg beats/min of 
RPP. 
Cardiac functional recovery 
Table 1. shows the recovery of hemodynamic data on the heart for 12 
hours of preservation [(A), absolute values of post-preservative cardiac 
function; (B), percentage values to the pre-preservative baseline function).The 
recovery of CF, CO, SP, MP, and LV dp/dt in the nicaraven group (Group 3) 
was significantly greater than that in the control group (Group 1). The 
recovery of CF in the nicaraven group also was superior to that in the SOD & 
CAT group (Group 2) (p<0.05). The recovery of CO in the nicaraven group 
showed a tendency to increase, compared with those in the SOD & CAT group 
(p=0.07). 
After the first 20-minute stabilization period, CF perfused with drug-free 
KHB solution was 5.1±0.6 ml/min in Group 1, 5.5 ± 0.4 ml/min in Group 2, 
and 5.8 ±0.4 ml/min in Group 3. After perfusion with KHB solution 
containing 5-HT, CF was 4.1±0.5 ml!min in Group 1, 4.6 ± 0.4 ml/min in 
Group 2, and 5.4 ±0.3 ml!min in Group 3. CF in Group 3 was higher than 
that in Group 1 (p<0.05)(Table 2). In addition, 5-HT caused a decrease in 
CF(Group 1, -20.5 ± 3.0 %; Group 2, -15.4 ± 4.8 %; Group 3, -5.9 ± 3.8 %) 
(Figure 2), compared with that of the heart perfused with drug-free KHB 
solution. However, this decrease of CF was less in the nicaraven group than in 
the control group (p<0.05)(Figure 2). 
After the next 20-minute stabilization period, CF perfused with drug-free 
KHB solution was 4.8±0.5 ml/min in Group 1, 5.3 ± 0.3 ml/min in Group 2, 
and 5.6±0.3 ml!min in Group 3. After perfusion with KHB solution containing 
NTG, CF was 5.2±0.4 ml/min in Group 1, 5.3 ± 0.4 ml/min in Group 2, and 
5.8 ±0.4 ml/min in Group 3. NTG caused a little increase in CF (Group 1, 8.8 
± 6. 7 %; Group 2, -0.6 ± 1.8 %; Group 3, 3.4 ± 1.3 %) (Figure 2), compared 
with that of the heart perfused with drug-free KHB solution. However, there 
were no significant differences in CF among the groups. 
CPK, Lactate and Troponin-T leakage 
The values of CPK leakage in Group 1, 2, and 3 were 0.1±0.0 IU/ min/g, 
0.1±0.1 IU/min/g, and 0.2±0.1 IU/min/g, respectively. The values of lactate 
leakage were 7.8±0.7 mg/min/g, 10.4±2.1 mg/min/g, and 9.6±0. 7 mg/min/g, 
respectively. The values of troponin-T leakage werel2.3±4.0 ng/min/g, 
12.9±3.7 ng/min/g, and 16.9±2.8 mg/min/g, respectively. There were no 
significant differences in CPK, troponin-T, and lactate leakage among the 
three groups. 
Water content 
The tissue water content was 83.5 ± 0.4 % in Group 1, 84.6 ± 1.5 % in 
Group 2, and 83.1 ± 1.3 % in Group 3. There were no statistically significant 
differences among the groups. 
Discussion 
The most important hypotheses explaining the cellular events involved in 
reperfusion damage are oxygen-derived free radical damage and calcium 
overload (2). Free radicals, such as the superoxide radical, hydrogen 
peroxide, and hydroxyl radical, probably exert their damaging effects by 
disrupting membrane lipids or membrane-bound proteins. These impaired cell 
membranes cause an increase in intracellular free calcium which may lead to 
reperfusion injuries such as reperfusion arrythmias, vascular damage and no-
reflow, and myocardial stunning (2,9). Xanthine oxidase may serve as the 
initial source of free radical generation in post-ischemic reperfusion injuries. 
During ischemia, ATP is degraded to its purine bases (e.g. hypoxanthine). At 
reperfusion, oxygen becomes available, suddenly and in exess, and the 
oxidation of hypoxanthine and xanthine proceeds rapidly, generating a burst 
of superoxide radicals and hydrogen peroxides which may overcome the 
endogenous ant ioxidant system (32). Therefore, conditions are created in 
which the highly reactive hydroxyl radicals can be produced (33). 
Hydroxyl radical formation can be prevented by the simultaneous 
scavenging of both superoxide and hydrogen perox ide radicals (10, 11 ). 
Alternatively, hydroxyl radicals might be susceptible to direct scavenging by 
hydroxyl radical scavengers (14-18). Whereas, superoxide dismutase (SOD) 
and catalase (CAT) metabolize superoxide radical and hydrogen peroxide, 
respectively, to benign metabolites (10,11), nicaraven may directly scavenge 
hydroxy l radicals (27-30). In this study, we investigated the protective effects 
of administering free radical scavengers following preservation and 
reperfusion (P/ R). We found better recovery of cardiac function in the 
nicaraven group than that in the non-treated control and SOD & CAT -treated 
groups. These results suggest that nicaraven may reduce myocardial P!R 
injury more effectively than combined treatment w ith both SOD and CAT. 
In the isolated rat heart, 5-hydroxytryptamine (5-HT) may cause 
coronary vasodilation by the release of endothel ium-derived relaxing factor 
(EDRF). However, when the release of EDRF is blocked or the endothelium is 
damaged, the vasoconstrictive effect of 5-HT on the coronary vasculature is 
unmasked (34). Therefore, 5-HT leads to an increase in coronary flow (CF) in 
the absence of coronary endothelial damage. In this study, 5-HT caused a 
decrease in CF, from which it may be postulated that the coronary 
endothelium was damaged during P/ R. Examination of cardiac function in the 
working mode revealed better recovery of CF in the nicaraven-treated group 
than that in SOD & CAT -treated and non-treated control groups. Nicaraven, 
thus, might have exerted a protective effect on the coronary endothelium that 
led to an attenuation of the decrease in CF induced by 5-HT following P/R. 
Halliwell et al. (22) have reported that the amount of free iron is limited 
or that iron and hydrogen peroxide are present in different compartments. 
Therefore, hydrogen pe roxide may not exert a damaging effect since the 
hydroxyl radical is not produced when iron and hydrogen peroxide do not 
come contact. The superoxide radical and hydrogen peroxide may not be 
directly toxic, but, instead, cellular injury might be more likely related to the 
subsequent generation of the more highly reactive hydroxyl radical (6-9). 
Thus, therapy with oxygen-free radica l scavengers should be directed toward 
inactivation of hydroxyl radicals, rather than the superoxide radical and/or 
hydrogen peroxide. It has been reported that SOD has an extremely short-half-
life which may limit its efficacy since considerably more time may be 
required until an effective tissue concentration is reached (35). It might be 
partly attributable to this reason that the recovery of cardiac function in the 
SOD/CAT-treated group did not improve as much as that in the non-treated 
control group. Weglicki et al. (36,37) have reported that scavengers such as 
SOD and CAT may fail to scavenge free radicals when they are generated 
within the membrane. Nicaraven, which is not only hydrophilic but also 
lipophilic, might be able to contact to and/or permeate a cell membrane and 
scavenge hydroxyl radicals formed at the cell membrane (27-30,37). This may 
explain the improvement in cardiac function in the nicaraven-treated group in 
this study. 
We have previously reported that HTK solution is superior to University 
of Wisconsin (UW) solution for cardiac preservation following 8-hour storage 
(in press). Therefore, in this study, we used HTK solution as a basal 
preservation solution and examined cardiac functions following a longer 12-
hour period of preservation. In our isolated heart model, neutrophils and 
platelets were absent from the perfusion solution, however, other sources of 
free radical production, such as mitochondria, catecholamine oxidation, 
arachidonic acid metabolism, and xathine oxidase system could have produced 
free radicals (38). Furthermore, the present study did not investigate the 
efficacy of administering free radical scavengers during reperfusion. The 
results of this study may indicate that for optimal sustained protection, 
prolonged administration of free radical scavengers (up to several hours) may 
be revealed in the setting of a blood-perfused transplanted heart. 
In conclusion, nicaraven, a hydroxyl radical scavenger attenuates P!R 
injury and improves the recovery of cardiac function . This may lead to a safe 
extension of the heart preservation time and improve morbidity and mortality 
rates for patients undergoing cardiac transplantation. Future studies of 
nicaraven pretreatment, combined with nicaraven administration during 
reperfusion, in the setting of prolonged hypothermic storage may be 
warranted to determine if further improvements in cardiac function can be 
obtained. 
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TABLE 1. (A) Cardiac Fun cti on al Reco very 
·------------------------------------------------------------
Time AF CF co SP MP RPP LVdp/ dt 
Group (hour) (ml/min) (ml/min) (ml/min) (mmHg) (mmHg) (X 1 Q3) 
---------
------
--- ·---------------- - -------- -----
1. 12 1.9:0.9 4.5: 1.3 6.6:2.4 44.1: 8 .8 27.5:5.5 7.3: 1.6 539 : 142 
2. 12 2.3: 0.4 6.0: 0.5 9.1 : 0.8 58 .3: 4.4 41 .3: 2.2 10.4: 2.1 757: 84 
3. 12 6.0: 2.3 9 .5:0 .8*# 15.6: 3 .1* 89.2:3 .0* 44 .6 : 1.4* 11 .2:1.6 960 : 48* 
(B) Card iac Funct ion al Recovery (%) 
~------------------------------------------------------------
Time AF CF co SP MP RPP 
Group (hour) (%) (%) (%) (%) (%) (%) 
----------------------------------- --------------------------------
1. 12 3 .9: 2 .3 29 .7: 9 .2 11 .7: 3.9 37 .9: 8.7 52 .9: 10 .5 28.1 : 6.4 
2. 12 5.1:0.9 43 .0:3. 1 15.0: 1.4 53.4: 3.7 75 .9: 3 .9 40.8: 8 .0 
3. 12 13.0 : 5 .4 62.8 :5. 6*# 25.6:5. 1* 61.0 : 3.9* 80.6 : 2.8* 42.7 : 6.0 
n=8 hearts per groups. Data are expressed as mean:S.E. The hemodynamics of the 
pre -preservative hearts were: AF(46.4:2.9 ml / min ), CF(15.4: 1.1 ml/ min), C0(61 .3: 
3.4 ml/min), HR(239:15 beats/min), SP(1 12.3:4.6 mmHg) , MP(55.3: 0.6 mmHg) and 
RPP(25634:421 mmHg beats/min) . 
*p<0.05 vs Group 1, #p<0.05 vs Group 2 
Group1, control group; Group2, SOD&CAT group; Group3, nicaraven group. 
SOD, superoxide dismutase 2.5x1 as U/ L; CAT, catalase 102 mg/ L; nicaraven, nicaraver 
1 0·3 M. 
AF, aortic flow ; CF, coronary flow; CO, cardiac output; HR, heart rate; 
SP, systolic pressure; MP, aortic mean pressure ; RPP, rate pressure product (mmHg 
beats/ min) 
Table 2. Coronary flow (ml / min) 
Group KHB(20 min) - 5-HT( 15 min) - KHB(20 min) - NTG(15 min) 
1.control 5.1 ±0 .6 4.1 ±0 .5 4 .8±0 .5 
2. SOD&CAT 5.5±0.4 4 .6±0.4 5.3±0 .3 
3. nicaraven 5.8 ±0.4 5.4±0.3* 5.6±0 .3 
n=8 hearts per groups. Data are expressed as mean±SE. 




SOD, superoxide dismutase 2.5x1 os U/ L ; CAT, catalase 102 mg/ L; nicaraven, 
nicaraven 1 0-3 M. 
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FIGURE 1. Experimental Protocol. The hearts were excised and mounted on a 
Langendorff apparatus (CD). They were arrested and stored for 12-hours, following 
measurement of baseline cardiac function in a W -mode (a> ,Q) ). Following cold 
storage, they were reperfused for 15 minutes on L-mode and 25 minutes on W-mode. 
The coronary perfusates were collected, following 10 minutes of W-mode reperfusion 
to evaluate for lactate, CPK, and troponin-T (@). Cardiac functional recovery was 
measured at the end of W -mode reperfusion and the hearts were switched back to L-
mode and paced in an atrial mode at 330 beats/ min (0> ). The coronary circulation was 
washed with the drug-free KHB for 20 minutes to establish the basal coronary flow 
(CF) (®). After the 20-minute stabilization period, the hearts were perfused with KHB 
solution containing 10-6M 5-HT for 15 minutes and CF was recorded for the last 2 
minutes of perfusion (CV). The coronary circulation was washed with the drug-free 
KHB solution again for the next 20 minutes to reestablish the basal CF (@). The hearts 
subsequently were perfused with KHB solution containing 10-5 M NTG for 15 
minutes and the CF was measured for the last 2 minutes of perfusion(@). W: working 
mode perfusion, L: Langendorf£ mode perfusion, CPK: creatine phosphokinase, KHB: 
Krebs-Henseleit bicarbonate buffer, 5-HT: 5-hydroxytryptamine, NTG: nitroglycerin, 
CF: coronary flow 
c 
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FIGURE 2. The coronary flow (CF) reaction to 5-HT and NTG, following preservation and reperfusion. 
CF after perfused with KHB solution containing 5-HT and NTG was calculated and expressed as a 
percentage of that of the heart perfused with drug-free KHB solution in each group. After 20-minute 
stabilization period, CF perfused with drug-free KHB solution in Group 1, 2, and 3 was 5.1±0.6ml/min, 5. 
5+0.4ml!min, 5.8±0.4ml/min, respectively. 5-HT caused a decrease in CF, compared with that of the heart 
perfused with drug-free KHB solution. However, this decrease was less in Group 3 than in Group 1 (*p<O. 
05). After the next 20-minute stabilization period, CF perfused with drug-free KHB solution in Group 1, 2, 
and 3 was 4.8±0.5ml/min, 5.3+0.3ml/min, 5.6+0.3ml/min, respectively. NTG caused no significant 
differences in CF among the groups. 
Group 1; control group, Group 2; SOD & CAT group, Group 1; nicaraven group. 
SOD, superoxide dismutase 2.5 x105 U/L; CAT, catalase 102 mg!L; nicaraven, nicaraven 10-3M. 
KHB, Krebs-Henseleit bicarbonate buffer 
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